PRN: Global Biotech Partnering Terms and Agreements Analysis Report 2010-2017

08/set/2017 18:45:11 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Biotech Partnering Terms and Agreements Analysis Report 2010-2017

 
[08-September-2017]
 

DUBLIN, September 8, 2017 /PRNewswire/ --

The "Global Biotech Partnering Terms and Agreements 2010-2017: Deal trends, players and financials" report has been added to Research and Markets' offering.

Research and Markets Logo

Global Biotech Partnering Terms and Agreements 2010 to 2017 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report provides details of the latest Biotech agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Biotech deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Biotech partnering deals.

The report presents financial deal term values for Biotech deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Biotech partnering field! ; both the leading deal values and most active Biotech dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 7,000 online deal records of actual Biotech deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

Key benefits:

  • In-depth understanding of Biotech deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Biotech agreements with real life case studies
  • Detailed access to actual Biotech contracts entered into by leading biopharma companies
  • Identify most active Biotech dealmakers since 2010
  • Insight into terms included in a Biotech partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

The available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Biotech dealmaking

Chapter 3 - Leading Biotech deals

Chapter 4 - Most active Biotech dealmakers

Chapter 5 - Biotech contracts dealmaking directory

Chapter 6 - Biotech dealmaking by technology type

Chapter 7 - Partnering resource center

For more information about this report visit https://www.researchandmarkets.com/research/d95d42/global_biotech

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl